Enzyme replacement therapy attenuates disease progression in two Japanese siblings with mucopolysaccharidosis type VI: 10-Year follow up

Early initiation of enzyme replacement therapy (ERT) has demonstrated clinical benefit in patients with mucopolysaccharidosis type VI (MPS VI), a progressive, multisystem autosomal recessive lysosomal disorder caused by N-acetylgalactosamine-4-sulphatase (ASB) deficiency and the consequent accumulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Furujo, Mahoko, Kosuga, Motomichi, Okuyama, Torayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622997/
https://www.ncbi.nlm.nih.gov/pubmed/28983456
http://dx.doi.org/10.1016/j.ymgmr.2017.08.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622997/
https://www.ncbi.nlm.nih.gov/pubmed/28983456
http://dx.doi.org/10.1016/j.ymgmr.2017.08.007

Ejemplares similares